OrbiMed’s Dimension Therapeutics, Inc DMTX Stock Holding History

OrbiMed’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,397,698	Closed	-$32.4M	–	156
2017 Q3	$32.4M	Hold	5,397,698	–	–	0.31%	75
2017 Q2	$7.83M	Hold	5,397,698	–	–	0.08%	104
2017 Q1	$9.45M	Hold	5,397,698	–	–	0.11%	99
2016 Q4	$23.5M	Hold	5,397,698	–	–	0.3%	64
2016 Q3	$43.1M	Hold	5,397,698	–	–	0.49%	57
2016 Q2	$32.4M	Hold	5,397,698	–	–	0.34%	63
2016 Q1	$42.3M	Hold	5,397,698	–	–	0.44%	52
2015 Q4	$60.9M	Buy	+5,397,698	New	+$68.3M	0.55%	49

OrbiMed's DMTX Position: Q4 2017 in Review

OrbiMed sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 5,397,698 shares — an estimated $32.4M sold.

OrbiMed first reported a position in DMTX in Q4 2015 and held it in 8 quarters. The position peaked at $60.9M in Q4 2015. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

OrbiMed reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
OrbiMed sold 5,397,698 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $32.4M.
OrbiMed first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 8 quarters.
OrbiMed's Dimension Therapeutics, Inc position peaked at $60.9M in Q4 2015.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on OrbiMed's 13F filing for Q4 2017, filed 14 Feb 2018.